Effect of Concomitant Bladder Neck Incision and Urethral Valve Ablation on Surgical Re-intervention Rate for Patients With Posterior Urethral Valve
Primary Purpose
Pediatric Disorder, Hydronephrosis in Children, Hydronephrosis, Secondary
Status
Unknown status
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Valve ablation
Valve ablation and bladder neck incision
Sponsored by
About this trial
This is an interventional treatment trial for Pediatric Disorder focused on measuring PUV, BNI, Urethral valve, Valve ablation, Bladder dysfunction
Eligibility Criteria
Inclusion Criteria:
- Patients who are less than 12 years of age with presenting to the Mansoura University Urology and Nephrology Center with the diagnosis of PUV will be s creended for eligibility
Exclusion Criteria:
- Patients with other conditions that can potentially affect lower and upper urinary tract functions
- Patients who were treated with urinary diversion as vesicostomy or cutaneous ureterostomy.
- Patients who had primary treatment of posterior urethral valve ablation at other hospitals.
Sites / Locations
- Urology and nephrology center, Mansoura university
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Valve ablation
Valve ablation and bladder neck incision
Arm Description
Valve ablation
Valve ablation and bladder neck incision
Outcomes
Primary Outcome Measures
compare numbers of reintervention between groups
assessed by calculating the number of patients needed surgical reintervention per total number of patients in both groups
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05087537
Brief Title
Effect of Concomitant Bladder Neck Incision and Urethral Valve Ablation on Surgical Re-intervention Rate for Patients With Posterior Urethral Valve
Official Title
Effect of Concomitant Bladder Neck Incision and Urethral Valve Ablation on Surgical Re-intervention Rate for Patients With Posterior Urethral Valve : A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
October 2021
Overall Recruitment Status
Unknown status
Study Start Date
October 1, 2021 (Actual)
Primary Completion Date
January 1, 2023 (Anticipated)
Study Completion Date
January 1, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Mansoura University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
To determine the short-term effects of concurrent valve ablation and bladder neck incision on re-intervention rate for patients with posterior urethral valve.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pediatric Disorder, Hydronephrosis in Children, Hydronephrosis, Secondary, Hydronephrosis Congenital, Bladder-Neck; Obstruction, Congenital, Urethral Valve, Renal Function Disorder
Keywords
PUV, BNI, Urethral valve, Valve ablation, Bladder dysfunction
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
62 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Valve ablation
Arm Type
Active Comparator
Arm Description
Valve ablation
Arm Title
Valve ablation and bladder neck incision
Arm Type
Active Comparator
Arm Description
Valve ablation and bladder neck incision
Intervention Type
Procedure
Intervention Name(s)
Valve ablation
Intervention Description
Valve ablation
Intervention Type
Procedure
Intervention Name(s)
Valve ablation and bladder neck incision
Intervention Description
Valve ablation and bladder neck incision
Primary Outcome Measure Information:
Title
compare numbers of reintervention between groups
Description
assessed by calculating the number of patients needed surgical reintervention per total number of patients in both groups
Time Frame
1 year
10. Eligibility
Sex
Male
Gender Based
Yes
Gender Eligibility Description
males less than 12 years old
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients who are less than 12 years of age with presenting to the Mansoura University Urology and Nephrology Center with the diagnosis of PUV will be s creended for eligibility
Exclusion Criteria:
Patients with other conditions that can potentially affect lower and upper urinary tract functions
Patients who were treated with urinary diversion as vesicostomy or cutaneous ureterostomy.
Patients who had primary treatment of posterior urethral valve ablation at other hospitals.
Facility Information:
Facility Name
Urology and nephrology center, Mansoura university
City
Mansoura
State/Province
Dakahlia
ZIP/Postal Code
35516
Country
Egypt
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Effect of Concomitant Bladder Neck Incision and Urethral Valve Ablation on Surgical Re-intervention Rate for Patients With Posterior Urethral Valve
We'll reach out to this number within 24 hrs